The UK government hopes that research and development will be boosted thanks to the Medicines Discovery Catapult, which aims to launch 22 partnerships with UK-based CROs.
The Medicines Discovery Catapult is a not-for-profit company funded by Innovate UK. They are a national facility, connecting the UK research community to accelerate innovative drug discovery.
The company has the potential to enable UK life sciences through its virtual R&D discovery services platform. The platform aims to connect relevant bodies in the UK with the goal of accelerating drug development and patient access. Platform capabilities range from full project review to assessing data and advice on development plans.
Dr Peter Simpson, Chief Scientific Officer at the Medicines Discovery Catapult, said:
“Our aim is to support SMEs and academia to deliver their own discovery projects through convenient access to excellent assays and specialist drug discovery services.
“UK-based CROs can meet a wide range of needs for drug discovery innovators, and we are delighted to work in partnership with them to provide advice and project management to help ensure these relationships are successful.”